Publicaciones en las que colabora con Irene Esparza Catalán (12)

2019

  1. Casein nanoparticles in combination with 2-hydroxypropyl-β-cyclodextrin improves the oral bioavailability of quercetin

    International Journal of Pharmaceutics, Vol. 570

2017

  1. Zein nanoparticles for oral delivery of quercetin: Pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 13, Núm. 1, pp. 103-110

2015

  1. Casein nanoparticles as carriers for the oral delivery of folic acid

    Food Hydrocolloids, Vol. 44, pp. 399-406

  2. Zein nanoparticles for oral folic acid delivery

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 450-457

  3. Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock

    Journal of Agricultural and Food Chemistry, Vol. 63, Núm. 23, pp. 5603-5611

2012

  1. Development of poly(anhydride) nanoparticles loaded with peanut proteins: The influence of preparation method on the immunogenic properties

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 82, Núm. 2, pp. 241-249

  2. Nanoparticulate adjuvants and delivery systems for allergen immunotherapy

    Journal of Biomedicine and Biotechnology, Vol. 2012

2011

  1. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery

    Expert Opinion on Drug Delivery, Vol. 8, Núm. 6, pp. 721-734

  2. La encapsulación como herramienta para la utilización de aditivos

    Los retos actuales de la industria alimentaria (Universidad de Burgos), pp. 87-124

  3. Nanomedicine: Novel approaches in human and veterinary therapeutics

    Veterinary Parasitology, Vol. 180, Núm. 1-2, pp. 47-71

  4. Nanoparticles for the Oral Administration of Cancer Therapies

    INTRACELLULAR DELIVERY: FUNDAMENTALS AND APPLICATIONS (SPRINGER), pp. 487-509

  5. Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators

    Vaccine, Vol. 29, Núm. 41, pp. 7130-7135